Last reviewed · How we verify

NCT05527171

Virtual Reality Mindfulness Meditation After ACL Reconstruction

Recruiting now NA Last updated 16 April 2025
What this trial tests

NA trial testing Virtual Reality Mindfulness Meditation in Anterior Cruciate Ligament Injury in 48 participants. Currently enrolling.

Timeline
5 September 2023
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorUniversity of North Carolina, Chapel Hill
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment48
Start date5 September 2023
Primary completion30 June 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 14 to 25, female only, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effect of virtual reality mindfulness meditation on patients after ACLR, the investigators will determine the effect of virtual reality mindfulness meditation to 1) decrease self-reported injury-related fear, 2) improve poor jump-landing movement patterns, and 3) improve brain activity in women 1 to 5 years post-ACLR when compared to a virtual reality sham group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Virtual Reality Mindfulness Meditation for Patients After Anterior Cruciate Ligament Reconstruction: Protocol for the Development of a National Institutes of Health Stage 1 Behavioral Intervention.
    Baez S, Marmura H, Pietrosimone B, Moser J. · · 2026 · PMID 42184365 · DOI 10.2196/91897

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Injury

Currently open trials in the same condition.

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05527171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing